Effects of a hydroxyapatite-based biomaterial on gene expression in osteoblast-like cells

Journal of Dental Research

Volumn 85, Issue 4, 2006, Pages 354-358

  Sibilla, P ^a   Sereni, A ^a   Aguiari, G ^a   Banzi, M ^a   Manzati, E ^a   Mischiati, C ^a   Trombelli, L ^a   Del Senno, L ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Biomaterial; Cell proliferation; Gene expression; Gene expression profile; Hydroxyapatite based biomaterial; Osteoblasts; Polycystin 2

Indexed keywords

ALKALINE PHOSPHATASE; BIOSTITE; COLLAGEN; GLYCOSAMINOGLYCAN; HYDROXYAPATITE;

ARTICLE; BONE DEVELOPMENT; BONE PROSTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROGENESIS; CYTOLOGY; CYTOSKELETON; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETICS; HUMAN; OSTEOBLAST; PROSTHESES AND ORTHOSES;

ALKALINE PHOSPHATASE; BONE SUBSTITUTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROGENESIS; COLLAGEN; CYTOSKELETON; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLYCOSAMINOGLYCANS; HUMANS; HYDROXYAPATITES; OSTEOBLASTS; OSTEOGENESIS; PROSTHESES AND IMPLANTS; TUMOR CELLS, CULTURED;

EID: 33646349731     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910608500414     Document Type: Article

References (30)

1. 2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells. FASEB J 18:884-886.
2. Anderson HC, Hsu HHT, Raval P, Reynold PR, Gurley DJ, Aguilera MX, et al. (1998). Bone-inducing agent in Saos-2 cell extracts and secretions. Cells Mater 8:89-98.
3. Benqué EP, Gineste M, Heughebaert M (1985). Histological study of the biocompatibility of hydroxyapatite crystals in periodontal surgery. J Biol Buccale 13:271-282.
4. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, et al. (2001). Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29:365-371.
5. Brett PM, Harle J, Salih V, Mihoc R, Olsen I, Jones FH, et al. (2004). Roughness response genes in osteoblasts. Bone 35:124-133.
6. Clover J, Gowen M (1994). Are MG-63 and HOS TE85 human osteosarcoma cell lines representative models of the osteoblastic phenotype? Bone 15:585-591.
7. Cowin SC, Weinbaum S, Zeng Y (1995). A case for bone canaliculi as the anatomical site of strain generated potentials. J Biomech 28:1281-1297.
8. Davis BA, Sipe B, Gershan LA, Fiacco GJ, Lorenz TC, Jeffrey JJ, et al. (1998). Collagenase and tissue plasminogen activator production in developing rat calvariae: normal progression despite fetal exposure to microgravity. Calcif Tissue Int 63:416-422.
9. Deyama Y, Takeyama S, Suzuki K, Yoshimura Y, Nishikata M, Matsumoto A (2001). Inactivation of NF-kappaB involved in osteoblast development through interleukin-6. Biochem Biophys Res Commun 282:1080-1084.
10. Filanti C, Dickson GR, Di Martino D, Ulivi V, Sanguineti C, Romano P, et al. (2000). The expression of metalloproteinase-2, -9, and -14 and of tissue inhibitors-1 and -2 is developmentally modulated during osteogenesis in vitro, the mature osteoblastic phenotype expressing metalloproteinase-14. J Bone Miner Res 11:2154-2168.
11. Froum SJ, Gomez C, Breault MR (2002). Current concepts of periodontal regeneration. A review of the literature. NY State Dent 768:14-22.
12. Harumiya S, Gibson MA, Koshihara Y (2002). Antisense suppression of collagen VI synthesis results in reduced expression of collagen I in normal human osteoblast-like cells. Biosci Biotechnol Biochem 66:2743-2747.
13. Kassner A, Hansen U, Miosge N, Reinhardt DP, Aigner T, Bruckner-Tuderman L, et al. (2003). Discrete integration of collagen XVI into tissue-specific collagen fibrils or beaded microfibrils. Matrix Biol 22:131-143.
14. Lambertini E, Penolazzi L, Sollazzo V, Pezzetti F, de Mattei M, del Senno L, et al. (2002). Modulation of gene expression in human osteoblasts by targeting a distal promoter region of human estrogen receptor-alpha gene. J Endocrinol 172:683-693.
15. Lincks J, Boyan BD, Blanchard CR, Lohmann CH, Liu Y, Cochran DL, et al. (1998). Response of MG63 osteoblast-like cells to titanium and titanium alloy is dependent on surface roughness and composition. Biomaterials 19:2219-2232.
16. Mackie EJ, Ramsey S (1996). Modulation of osteoblast behavior by tenascin. J Cell Sci 109(Pt 6):1597-1604.
17. Mayr-Wohlfart U, Waltenberger J, Hausser H, Kessler S, Gunther KP, Dehio C, et al. (2002). Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 30:472-477.
18. Ozawa S, Kasugai S (1996). Evaluation of implant materials (hydroxyapatite, glass-ceramics, titanium) in rat bone marrow stromal cell culture. Biomaterials 17:23-29.
19. Parodi R, Santarelli G, Carusi G (1996). Application of slow-resorbing collagen membrane to periodontal and peri-implant guided tissue regeneration. Int J Periodont Rest Dent 16:174-185.
20. Plantin P, Durigon M, Boileau C, Le Parc J (2000). Fibrillin network in normal bone tissue [article in French]. Ann Pathol 20:115-118.
21. Scabbia A, Trombelli L (2004). A comparative study on the use of a HA/collagen/chondroitin sulphate biomaterial (Biostite) and a bovine-derived HA xenograft (Bio-Oss) in the treatment of deep intra-osseous defects. J Clin Periodontol 31:348-355.
22. Sendide K, Reiner NE, Lee JS, Bourgoin S, Talal A, Hmama Z (2005). Cross-talk between CD14 and complement receptor 3 promotes phagocytosis of mycobacteria: regulation by phosphatidylinositol 3-kinase and cytohesin-1. J Immunol 174:4210-4219.
23. Serre CM, Papillard M, Chavassieux P, Boivin G (1993). In vitro induction of a calcifying matrix by biomaterials constituted of collagen and/or hydroxyapatite: an ultrastructural comparison of three types of biomaterials. Biomaterials 14:97-106.
24. Settleman J (1999). Rho GTPases in development. Prog Mol Subcell Biol 22:201-229.
25. Spector JA, Mehrara BJ, Greenwald JA, Saadeh PB, Steinbrech DS, Bouletreau PJ, et al. (2001). Osteoblast expression of vascular endothelial growth factor is modulated by the extracellular microenvironment. Am J Physiol Cell Physiol 280:C72-C80.
26. Sutters M, Germino GG (2003). Autosomal dominant polycystic kidney disease: molecular genetics and pathophysiology. J Lab Clin Med 141:91-101.
27. Sykaras N, Opperman LA (2003). Bone morphogenetic proteins (BMPs): how do they function and what can they offer the clinician? J Oral Sci 45:57-73.
28. Tille JC, Pepper MS (2002). Mesenchymal cells potentiate vascular endothelial growth factor-induced angiogenesis in vitro. Exp Cell Res 280:179-191.
29. Uemura T, Dong J, Wang Y, Kojima H, Saito T, Iejima D, et al. (2003). Transplantation of cultured bone cells using combinations of scaffolds and culture techniques. Biomaterials 24:2277-2286.
30. Whitfield JF (2003). Primary cilium-is it an osteocyte's strain-sensing flowmeter? J Cell Biochem 89:233-237.